Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
Stopped Slow accrual
Conditions
- Graft Versus Host Disease
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Secondary Myelofibrosis
Interventions
- DRUG: cyclophosphamide
- DRUG: cyclosporine
- DRUG: fludarabine phosphate
- DRUG: mycophenolate mofetil
- PROCEDURE: Treg cell infusion
- PROCEDURE: umbilical cord blood transplantation
- RADIATION: total-body irradiation
Sponsor
Masonic Cancer Center, University of Minnesota